Gain Exposure to Blockchain-Derived Health Markets through a Familiar Product
AVEX.AI is the first-ever tracker certificate issued on the Swiss Stock Exchange (The Six) designed to participate in the dynamic tokenized health market. It is a structured product following Swiss guidelines that utilizes a securitization pathway via wrapped tokens.
AVEX.AI offers a secure way of participating in blockchain-derived assets, ensuring that investors can take advantage of the opportunities in this new exponential space, while being secure with the type of instrument used.
With AVEX.AI, there is no learning curve or technological specialization required to access new health cryptoassets. It provides a simple tool that works with the familiarity of classic investment.
AVEX.AI Product Profile
The AVEX Token is the blockchain-derived currency that allows consumers and other members of the BIOSPHERES Network to transact within the BIOSPHERES platform. It was designed to capture the value of the health innovation sector. BIOSPHERES is a marketplace that accommodates billions of dollars in biotech/medical product offerings that offer solutions, from Alzheimer’s, to ALS, and Cancer, to millions of patients worldwide.
The AVEX Token is also the first to launch a new digital asset on a stock exchange through a structured product. Opportunities for new token offerings were previously exclusive to a highly technical community that generated unprecedented returns for many early investors. With this new alternative investment product, we make it as easy as buying a stock and reduce the risks that have been associated with other cryptocurrency offerings.
AVEX.AI Tracker Certificate on
Aevolve Token (AVEX)
Tracker-Certificate (Code 1300) of the Swiss Derivative Map, as amended from time to time by the Swiss Structured Products Association (www.svsp-verband.ch)
AVEX token is the sole and exclusive cryptoasset that is used to purchase unique health tech products in BIOSPHERES, a tokenized marketplace for health innovation offerings.
USD 100’000’000.00 (Maximal Amount)
Minimum Trade Size
10 Certificates and 1 Certificate thereafter
To Be Announced
FP ISSUER LIMITED (GUERNSEY)
Merging Traditional Finance with Innovation
Aevolve understands the value of working with existing regulatory framework to provide timely access and mutual benefits through an unprecedented interaction of investors and innovators.
Through tokenization and securitization of digital assets, value is captured in the health innovation space by introducing cutting-edge products and making them accessible to the public. By integrating this new cryptoasset strategy with trusted investment protocols, a new hybrid market is invented that brings the trillion-dollar derivative market into innovation financing, and enables investment opportunities and liquidity to flow between both ecosystems.
AVEX.AI is a classic investment that is understandable and avoids technological mishaps in large-scale investing, such as mismanagement of private keys. It has eliminated such risks by securely vaulting the underlying AVEX digital asset, and allows for free trading on traditional exchanges without exposure to new user related security risks.
AVEX.AI is a familiar product that requires no learning curve or technological shift. Investors that prefer traditional investment methods will find it the ideal, user-friendly option for accessing cutting-edge crypto markets.
There is a tremendous global need in the health sector, with many diseases constantly requiring solutions. This presents a wide range of opportunities to provide products or services that address these countless medical needs for the world’s growing population, new demand is continuously created. Therefore, market relevance is sustained fueling growth and new opportunities.
This is a first-in-the-world financial product that gives traditional financial managers exposure to a cryptotoken at it earliest stage. The regulatory and compliance landscape for cryptoassets is unclear and uncertain. This structured asset helps to break through fear, uncertainty and doubt associated with a new technology.
This investment tool is geared towards sustainability and future success by being a well-rounded mechanism beyond marketing and financial performance. It was designed with social impact ingrained in the business model, as well as well-designed governance levers in mind to protect asset owners. Further value is added by benefiting large communities in terms of an active donation market. By today’s standards ESG (Environmental, Social and Governance) Investing is considered a sound metric for investment strength. It proves to be a more sustainable method of investment, relying on transformative social contributions that outlast short-term marketing and price-boosting efforts.
Pricing models and projections are based on actual solutions that will launch as part of BIOSPHERES offerings. This is a high-practicality model for executing utility based on existing technologies. It is a measurable, executable and relatively low-cost build with realistic and achievable targets. With Year One targets secured, the project continues to ensure a lineup of multi-billion dollar offerings.